MRI contrast-enhancing agents Clinical Trials

2 actively recruiting trials across 1 location

Filter by location:

Birmingham, Alabama2 trials

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

University of Alabama at Birmingham- Site Number : 8401135

Phase 3

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

Alabama Neurology Associates- Site Number : 8400115

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.